Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273: A randomised VACCELERATE trial in adults ?75 years (EU-COVAT-1) - Neuhann, JM; Stemler, J; Carcas, AJ; Frías-Iniesta, J; Akova, M; Bethe, U; Heringer, S; Salmanton-García, J; Tischmann, L; Zarrouk, M; Cüppers, A; Grothe, J; et al. (Vaccine, 2023)